NCT05712941
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05712941 |
| Title | Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer |
| Recruitment | Withdrawn |
| Gender | female |
| Phase | Phase III |
| Variant Requirements | Yes |
| Sponsors | EQRx International, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries |
CKB BOOST